Severe Renal Impairment
6 clinical trials · Condition
◉ Watch Severe Renal Impairment
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) (NCT07734610) | Merck Sharp & Dohme LLC | 2026-08-17 |
| Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function (NCT04119843) | Ascelia Pharma AB | 2020-02-19 |
| A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease (NCT03165071) | Idorsia Pharmaceuticals Ltd. | 2017-06-03 |
| Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease (NCT02207088) | AbbVie | 2014-09-23 |
| A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine (NCT01675973) | Gilead Sciences | 2012-07-01 |
| Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers (NCT01043094) | Kowa Research Institute, Inc. | 2009-12-01 |
Track Severe Renal Impairment automatically
Every clearance here is in the API, with alerts when new ones post.